Abstract
Cure of invasive bladder cancer is possible only if all disease is eradicated. For the primary tumor this usually requires total cystectomy. In selected cases, complete excision can be accomplished by TUR [1] or partial cystectomy [2]. These methods have the advantage of bladder preservation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Herr HW: Conservative management of muscle-infiltrating bladder cancer. J Urol 138:1162, 1987.
Whitmore WF: Management of invasive neoplasms. Semin Urol 1:4, 1983.
Whitmore WF: Personal communication.
Sternberg CN, Yagoda A, Scher HI, et al.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139:461, 1988.
Scher HI, Herr HW, Yagoda A, et al.: Neoadjuvant M-VAC effect on the primary bladder lesion. J Urol 139:470, 1988.
Scher HI, Herr HW, Sternberg C, et al.: Neoadjuvant chemotherapy for invasive bladder cancer: Experience with the M-VAC regimen. Br J Urol 64:250, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herr, H.W., Scher, H.I. (1992). Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. In: Lepor, H., Lawson, R.K. (eds) Therapy for Genitourinary Cancer. Cancer Treatment and Research, vol 59. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3502-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3502-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6553-2
Online ISBN: 978-1-4615-3502-7
eBook Packages: Springer Book Archive